hyperhomocysteinemia
Conditions
Interventions
Case series:B treatment + VB2 + betaine
Sponsors
China Rehabilitation Research Center, Beijing Boai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: Patients in the ward and outpatient Hhcy can take regular medication and collect blood according to the time point, without severe liver and kidney dysfunction, and sign informed consent. Sequential enrollment in Hhcy patients, fill in CRF, determine baseline HCY / folic acid / VB12 / liver and kidney function; folic acid, vitamin B6, mecobalamin after routine treatment for 1 month, review Hcy levels, screening out less than 20% or not normal Value (60 cases). They were randomly divided into the conventional treatment group and the combination treatment group.
Exclusion criteria
Exclusion criteria: Patients who had been treated for HCY in the external hospital were not included in the study group.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Methionine synthase;Cystathionine B synthetase; | — |
Primary
| Measure | Time frame |
|---|---|
| Folic acid;Methylenetetrahydrofolate reductase;vitamin B12; | — |
Countries
China
Contacts
Public ContactDu Xiao-Xia
China Rehabilitation Research Center Beijing Boai Hospital
Outcome results
None listed